Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease - PubMed (original) (raw)

Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease

K A Harrington et al. Brain Res Mol Brain Res. 1996 Feb.

Abstract

The cellular expression of DAT mRNA and VMAT2 mRNA was investigated in sections of the human post-mortem substantia nigra in control and Parkinson's disease tissue using in situ hybridisation techniques. Short synthetic oligodeoxynucleotides were used to detect these gene transcripts at the cellular level. In the control human nigra, high levels of expression were seen in all sub-divisions of the substantia nigra, especially within medial regions. By contrast, the level of expression of both DAT mRNA and VMAT2 mRNA was markedly reduced in Parkinson's disease; these reductions in hybridisation signal were associated with (i) a marked loss of dopamine-containing cells in the substantia nigra, and (ii) a reduction in both DAT and VMAT2 signal per cell in the remaining pigmented neurones. These disease-related decreases in the cellular abundance of both DAT and VMAT2 gene transcripts in the surviving cells of the parkinsonian nigra may reflect compensatory changes in catecholamine signalling or may be a consequence of neuronal dysfunction.

PubMed Disclaimer

Cited by

State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.
Basso V, Döbrössy MD, Thompson LH, Kirik D, Fuller HR, Gates MA. Basso V, et al. Biology (Basel). 2024 Sep 3;13(9):690. doi: 10.3390/biology13090690. Biology (Basel). 2024. PMID: 39336117 Free PMC article. Review.
Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson's disease.
de Laat B, Hoye J, Stanley G, Hespeler M, Ligi J, Mohan V, Wooten DW, Zhang X, Nguyen TD, Key J, Colonna G, Huang Y, Nabulsi N, Patel A, Matuskey D, Morris ED, Tinaz S. de Laat B, et al. NPJ Parkinsons Dis. 2024 Feb 9;10(1):34. doi: 10.1038/s41531-024-00641-1. NPJ Parkinsons Dis. 2024. PMID: 38336768 Free PMC article.
Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
Atiq A, Lee HJ, Khan A, Kang MH, Rehman IU, Ahmad R, Tahir M, Ali J, Choe K, Park JS, Kim MO. Atiq A, et al. Int J Mol Sci. 2023 Jun 9;24(12):9942. doi: 10.3390/ijms24129942. Int J Mol Sci. 2023. PMID: 37373089 Free PMC article.
The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson's Disease.
Kolacheva A, Pavlova E, Bannikova A, Bogdanov V, Troshev D, Ugrumov M. Kolacheva A, et al. Int J Mol Sci. 2023 Feb 3;24(3):3027. doi: 10.3390/ijms24033027. Int J Mol Sci. 2023. PMID: 36769355 Free PMC article.
Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes.
Padilla-Godínez FJ, Ruiz-Ortega LI, Guerra-Crespo M. Padilla-Godínez FJ, et al. Cells. 2022 Oct 31;11(21):3445. doi: 10.3390/cells11213445. Cells. 2022. PMID: 36359841 Free PMC article. Review.

Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease - PubMed (original) (raw)